Here we developed synthetic transactivation domains (TADs) built from human mechanosensitive transcription factors (MTFs). By linking MTF TAD segments together, we engineered compact and potent multipartite transcriptional activation modules. We then harnessed these modules to create a CRISPR activation system, which we termed the dCas9 recruited enhanced activation module (CRISPR-DREAM).
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451 (2013). This article was one of the first studies to demonstrate CRISPR-mediated transcriptional regulation in human cells.
Wang, K. et al. Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer-promoter interactions. Nucleic Acids Res. 50, 7842–7855 (2022). This article compared the expression levels and relative efficacies of different state-of-the-art CRISPRa tools in human cells.
Weuring, W. J. et al. CRISPRa-mediated upregulation of scn1laa during early development causes epileptiform activity and dCas9-associated toxicity. CRISPR J. 4, 575–582 (2021). This article demonstrates that some CRISPRa tools can be toxic in some contexts.
Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR–Cas9 complex. Nature 517, 583–588 (2015). In this article, the authors developed the potent and widely used SAM CRISPRa tool.
Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326–328 (2015). In this article, the authors developed the potent and widely used dCas9–VPR tool.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Mahata, B. et al. Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control. Nat. Methods https://doi.org/10.1038/s41592-023-02036-1 (2023).
Rights and permissions
About this article
Cite this article
Combining compact human protein domains with CRISPR systems for robust gene activation. Nat Methods 20, 1635–1636 (2023). https://doi.org/10.1038/s41592-023-02038-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41592-023-02038-z